title: Anaphylaxis in immunotherapy.
abstract: Although anaphylactic reactions resulting from immunotherapy rarely occur, when they do occur they can be life-threatening. The literature reveals more than 30 deaths attributed to immunotherapy but numerous reports of anaphylaxis. We reviewed a 5-year experience of immunotherapy in a University practice and their experience with systemic reactions is presented. More than 125,000 injections were given in this time period. Of the 550 patients receiving immunotherapy, 14% experienced anaphylactic reactions, the majority of which were mild.
authors.forename: W E
authors.initials: WE
authors.lastname: Davis
authors.forename: P R
authors.initials: PR
authors.lastname: Cook
authors.forename: J P
authors.initials: JP
authors.lastname: McKinsey
authors.forename: J W
authors.initials: JW
authors.lastname: Templer
mesh_terms: D000707:Anaphylaxis / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D001249:Asthma / Q000628:therapy*; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects*; D007267:Injections; D008297:Male; D012189:Retrospective Studies; D013997:Time Factors